Navigation Links
AtriCure Reports Record Second Quarter 2008 Financial Results
Date:8/5/2008

150 253,125

Net cash used in operating

activities (6,510,125) (5,622,732)

Cash flows from investing activities:

Purchases of property & equipment (1,092,423) (1,441,494)

Purchases of available-for-sale

securities (1,903,974) -

Maturities of available-for-sale

securities 7,000,000 3,608,000

Cash paid for acquisition (417,292) -

Net cash provided by investing

activities 3,586,311 2,166,506

Cash flows from financing activities:

Payments on debt and capital leases (221,139) (191,798)

Proceeds from stock option exercises 174,122 151,345

Gross proceeds from sale of stock - 16,499,997

Net cash (used in) provided by

financing activities (47,017) 16,459,544

Effect of exchange rate changes on

cash (6,379) (157,452)

Net (decrease) increase in cash and

cash equivalents (2,977,210) 12,845,866

Cash and cash equivalents - beginning

of period 13,000,652 14,890,383

Cash and cash equivalents - end of

period $10,023,442 $27,736,249


'/>"/>
SOURCE AtriCure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. AtriCure Announces Web Cast and Conference Call of Second Quarter 2008 Financial Results
2. AtriCure Reports First Quarter 2008 Financial Results
3. AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy(TM) Bipolar Ablation System to Treat Atrial Fibrillation
4. AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008
5. eResearchTechnology Reports Second Quarter 2008 Results
6. SuperGen Reports 2008 Second Quarter Financial Results
7. Neurobiological Technologies Reports Receipt of $2.1 Million Royalty Payment for Quarterly Sales of Memantine
8. InterMune Reports Second Quarter 2008 Financial Results and Business Highlights
9. CV Therapeutics Reports 2008 Second Quarter Financial Results
10. Gentiva Reports Strong Second Quarter led by Home Health Segment
11. United Therapeutics Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... July 02, 2015 , ... In’Tech Medical SAS ( http://www.intech-medical.com ... announced today the acquisition of Turner Medical, Inc ., thus becoming a ... to the Spine Industry. The acquisition of Turner Medical ideally supplements In’Tech Medical’s ...
(Date:7/1/2015)... 2015   Decision Resources Group finds ... Otezla are its oral administration, alternative mechanism of ... surveyed rheumatologists. Otezla was the first oral therapy ... active psoriatic arthritis in the United ... includes conventional oral treatments including disease-modifying antirheumatic drugs ...
(Date:7/1/2015)... 1, 2015   Neuraltus Pharmaceuticals, Inc. , a ... groundbreaking drugs to treat neurodegenerative diseases such as ... Robert G. Miller , M.D., Director of the Forbes ... Pacific Medical Center in San Francisco, has been awarded ... million to help fund a Phase 2 clinical ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... A newly ... new ideas to lower the barriers to innovation in life sciences R&D. The Pistoia ... to two cash prizes of US$15,000 and a period of expert mentorship from a ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
... The Alfred E. Mann Foundation for,Biomedical Engineering (AEMFBE), ... establish university-based commercialization-,enablement institutes at elite universities, designed to ... announced the launch of,a Web site ( http://www.mannfbe.org ). ... the web site include: , ...
... BNVI ), a pharmaceutical company focused on the discovery and,development of ... announced that Isaac Cohen, Chairman and CEO of Bionovo, will be,presenting ... Health,Care Conference at 8 a.m. EST on December 3, 2008. ... New York City. , The ...
... Dec. 2 The Patient,Advocate Foundation (PAF), with support ... launch of the Lymphedema CareLine (LCL). PAF, through,its MedCare ... provide information and assistance to breast cancer,patients who are ... such as,lymphedema (swelling due to blockage in the lymphatic ...
Cached Biology Technology:Alfred Mann Foundation for Biomedical Engineering Launches New Web Site Designed to Help University Researchers Bring Biomedical Advances to Market 2Bionovo to Present at the Piper Jaffray Healthcare Conference 2New Program Offers Breast Cancer Clinicians and Patients Support for Pre-Operative Clinical Assessment and Ongoing Surveillance of Lymphedema 2New Program Offers Breast Cancer Clinicians and Patients Support for Pre-Operative Clinical Assessment and Ongoing Surveillance of Lymphedema 3
(Date:6/29/2015)... , June 24, 2015 ... addition of the "Latin America Biomedical Sensors Market ... their offering. The Latin America Biomedical Sensors ... a CAGR of 2.04% over the period 2014-2020 ... are adaptable to the genetic formulation of each individual. ...
(Date:6/25/2015)... 2015 According to a ... & Area), Technology, Material (Optical Prism, Piezoelectric, Capacitive ... & Others) & Geography - Global Forecast to ... market is expected to reach $14,500.07 Million by ... Browse 76 market Tables and 109 Figures ...
(Date:6/25/2015)... , June 25, 2015  TAKE Solutions Ltd., ... patent by the United States Patent and Trademark Office ... This process leverages TAKE Solutions, Clinical Accelerators to reduce ... 50% (when compared to standardization without the accelerators), thus ... At the heart of the ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4TAKE Solutions Awarded Patent By USPTO 2
... of the peskiest household pests, while disastrous to homes, could ... Purdue University study. Mike Scharf, the O. Wayne Rollins/Orkin ... has discovered a cocktail of enzymes from the guts of ... that inhibit fuel production from woody biomass. The Scharf Laboratory ...
... A study from the microbiology lab at the Lifespan hospitals ... in identifying Clostridium difficile Toxin ( C. diff ... a molecular method detects up to 50 percent more cases ... technology is more expensive, it allows for more cases to ...
... Speculation that the welfare of a small, ... in part supported by new scientific research, according to a ... Ecosphere , a journal of the Ecological Society of America. ... whose population has plummeted over the last 15 years, has ...
Cached Biology News:Termites' digestive system could act as biofuel refinery 2Not all tests are created equal: Identifying C. diff in hospital labs 2Research bolsters importance of horseshoe crab spawning for migrating shorebirds 2
...
... II identification and library ... module that adds capabilities ... and identification of unknowns ... entries of the same ...
Fingerprinting II cluster analysis is an optional module that adds dendrogram and phylogenetic tree construction, cluster and group significance, and congruence of techniques functions to the Fingerp...
Fingerprinting II Informatix optional matrix types module, is an optional module that adds external similarity and distance matrix functions to the Fingerprinting II Informatix software package....
Biology Products: